free insurance check for glp 1 GLP-1 Coverage Statistics 2026 | Employer, Medicare & Medicaid Data Ro launches the GLP-1 Insurance

Obesity is recognized as a chronic disease that can increase the risk of diabetes, heart disease, stroke, and other serious health conditions

Retrieved January 5, 2023, from Funding Open access funding provided by SCELC, Statewide California Electronic Library Consortium

The resulting impact on diet and nutrition means there is absolutely a growing opportunity in Europe for bespoke products for GLP-1 drug users, says Suketu Patel, global chief medical officer at Havas, which launched its own consultancy dedicated to GLP-1 innovation in June

More specifically, semaglutide and tirzepatide activate the GLP-1 receptor, promoting downstream pathways that are important for appetite regulation, insulin sensitivity and metabolism

These results were published in February 2025 (Hendershot, Bremmer, Paladino)

Recent guidelines suggest considering surgery at lower BMI thresholds (30 kg/m) for patients with type 2 diabetes